Pranjal Gambhir Appointed as Head of Medical Technology at Lazard

Pranjal Gambhir Takes Charge as Lazard's Head of Medical Technology

On September 28, 2026, Lazard, Inc. (NYSE: LAZ) made a significant announcement regarding leadership changes within its financial advisory team. Pranjal Gambhir has officially joined the firm as the Head of Medical Technology, headquartered in New York City. This appointment is expected to further solidify Lazard's position in the healthcare sector, particularly in medical technology investments and strategies.

Pranjal brings with him a wealth of experience, having spent two decades at Citi, where he played a critical role as a Managing Director overseeing Medical Technology companies. His expertise spans multiple sub-sectors of the medical technology field, making him a valuable addition to Lazard’s Healthcare Group. David Gluckman, Lazard's Global Head of Healthcare, expressed his enthusiasm about Gambhir’s onboarding. He stated, "Pranjal has broad and deep experience across the Medical Technology sector, and his arrival deepens the coverage we can offer clients. His background across multiple sub-sectors gives our Healthcare Group added strategic depth as we continue to grow our practice."

With the medical technology industry continuously evolving, there are emerging challenges and opportunities for stakeholders involved. Pranjal will advise clients on strategy and corporate development transactions, helping them navigate this complex landscape. In his own words, Gambhir noted, "The Medical Technology sector continues to evolve rapidly, creating both opportunity and complexity for clients. Lazard's independent perspective and global platform are exactly what leadership teams, boards, and investors need. I look forward to helping them navigate what's ahead."

Gambhir’s credentials include an MBA from the Indian School of Business and a Bachelor of Commerce from Delhi University. Over his extensive career, he has developed a reputation for strategic insight and this has poised him to help clients capitalize on trends in medical technology innovations.

Founded in 1848, Lazard is known for its counsel on mergers and acquisitions, as well as capital markets and asset management services. Their commitment to providing comprehensive advice on strategic matters has made them a go-to firm for institutions, corporations, and high-net-worth individuals seeking bespoke investment solutions.

As Gambhir steps into this pivotal role, the healthcare investment community will be watching closely. His prior experience at Citi, combined with Lazard's robust platform, is expected to enhance the firm's advisory capabilities in the medical technology space significantly. Lazard’s continuous objective to provide tailored financial solutions aligns seamlessly with Gambhir’s expertise, promising notable advancements in the healthcare sector.

In sum, Pranjal Gambhir’s appointment marks a new chapter for Lazard as it strengthens its advisory services for the medical technology industry. Under his guidance, clients can expect forward-thinking strategies that leverage Lazard’s established global platform. The expertise he brings positions Lazard to better serve its clients’ needs amidst a rapidly changing environment in healthcare technology. The financial community anticipates high-impact developments as Gambhir and his team work towards navigating complex transactions and fostering deeper relationships with medical technology firms globally.